eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   o   Check drugs   o   Compare drugs   o   Report a side effect
Join a support group   o   Ask a question   o   Write a review   o   Answered/ Unanswered   o   Reviews

Review: could Citalopram hydrobromide cause Vertebral-basilar artery occlusive syndrome (Aortic arch syndrome)?

Summary: Vertebral-basilar artery occlusive syndrome is reported only by a few people who take Citalopram hydrobromide.

We study 23,305 people who have side effects while taking Citalopram hydrobromide from FDA and social media. Find out below who they are, when they have Vertebral-basilar artery occlusive syndrome and more.

You are not alone: join a support group for people who take Citalopram hydrobromide and have Vertebral-basilar artery occlusive syndrome >>>

 

Citalopram hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from 24,930 Citalopram hydrobromide users)

Vertebral-basilar artery occlusive syndrome

Vertebral-basilar artery occlusive syndrome (decrease of blood flow in the vertebral or basilar arteries due to atherosclerosis or compression placed on the external wall of the arteries) has been reported by people with osteopenia, depression, chronic obstructive pulmonary disease, sleep disorder, multiple myeloma. (latest reports from 68 Vertebral-basilar artery occlusive syndrome patients)

On Mar, 6, 2015: 23,305 people reported to have side effects when taking Citalopram hydrobromide. Among them, 1 people (0.00%) has Vertebral-basilar Artery Occlusive Syndrome.

Trend of Vertebral-basilar artery occlusive syndrome in Citalopram hydrobromide reports

Time on Citalopram hydrobromide when people have Vertebral-basilar artery occlusive syndrome * :

n/a

Age of people who have Vertebral-basilar artery occlusive syndrome when taking Citalopram hydrobromide * :

0-12-910-1920-2930-3940-4950-5960+
Vertebral-basilar artery occlusive syndrome0.00%0.00%0.00%0.00%0.00%0.00%0.00%100.00%

Severity of Vertebral-basilar artery occlusive syndrome when taking Citalopram hydrobromide ** :

n/a

How people recovered from Vertebral-basilar artery occlusive syndrome ** :

n/a

Top conditions involved for these people * :

  1. Renal failure chronic (1 people, 100.00%)

Top co-used drugs for these people * :

  1. Detrol (1 people, 100.00%)
  2. Procrit (1 people, 100.00%)
  3. Pantoprazole (1 people, 100.00%)
  4. Vitamin d (1 people, 100.00%)
  5. Furosemide (1 people, 100.00%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of citalopram hydrobromide and vertebral-basilar artery occlusive syndrome on

Do you have Vertebral-basilar Artery Occlusive Syndrome while taking Citalopram Hydrobromide?

 

 

 

You are not alone! Join a support group on :
- support group for people who take Citalopram hydrobromide and have Vertebral-basilar Artery Occlusive Syndrome
- support group for people who take Citalopram hydrobromide
- support group for people who have Vertebral-basilar Artery Occlusive Syndrome

Drugs in real world that are associated with:

Could your condition cause:

Recent related drug studies (Check your drugs):

Recent Citalopram hydrobromide related drug comparison:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.